You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

Medical device company NeuroMetrix gets FDA clearance to market a pain management system

NeuroMetrix Inc., a Waltham-based medical device company, said it has gotten regulatory clearance to market a device that helps manage chronic pain in the lower leg or foot.

The device is called the SENSUS Pain Management System, and it’s a lightweight electrical nerve stimulator that is worn on the upper calf and activated by the press of a button. According to the company’s website, trancutaneous electrical nerve stimulation has been shown to provide pain relief for patients with diabetes. 

Continue reading below

In its press release, NeuroMetrix said that it has received 510(k) clearance from the Food and Drug Administration for the disposable electrode that is used in conjunction with its SENSUS device. This regulatory determination by the FDA gives NeuroMetrix clearance to market the SENSUS Pain Management System in the US market, the company said.

In a statement, company president and chief executive Shai N. Gozani said: “FDA clearance of the SENSUS electrode represents the last step in the regulatory pathway for the SENSUS Pain Management System. We believe that physicians treating patients with painful diabetic neuropathy, a severe and debilitating form of chronic pain, will find SENSUS to be a useful therapeutic option. We intend to initiate the commercial launch for SENSUS before the end of the year, in line with the goal that we set over a year ago.”

Chris Reidy can be reached at reidy@globe.com.

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week